373 results
Keyword Amox Remove keyword
-
List item
Opinion/decision on a Paediatric investigation plan (PIP): clarithromycin
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Gastroentology-Hepatology
PIP number: EMEA-001614-PIP01-13, Route(s) of administration: Oral use, Pharmaceutical form(s): Orodispersible tablet, Film-coated tablet, Gastro-resistant tablet, Tablet
Decision date: 18/06/2014, Last updated: 22/07/2014, Compliance check: Xclarithromycin (in combination with amoxicillin + metronidazole + pantoprazole … clarithromycin (in combination with amoxicillin + metronidazole + pantoprazole … clarithromycin (in combination with amoxicillin + metronidazole + pantoprazole … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Metronidazole
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Gastroentology-Hepatology
PIP number: EMEA-001615-PIP01-13, Route(s) of administration: Oral use, Pharmaceutical form(s): Orodispersible tablet, Film-coated tablet, Gastro-resistant tablet, Tablet
Decision date: 18/06/2014, Last updated: 22/07/2014, Compliance check: Xmetronidazole (in combination with amoxicillin + clarithromycin + pantoprazole … metronidazole (in combination with amoxicillin + clarithromycin + pantoprazole … metronidazole (in combination with amoxicillin + clarithromycin + pantoprazole … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): pantoprazole
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Gastroentology-Hepatology
PIP number: EMEA-001616-PIP01-13, Route(s) of administration: Oral use, Pharmaceutical form(s): Orodispersible tablet, Film-coated tablet, Gastro-resistant tablet, Tablet
Decision date: 18/06/2014, Last updated: 22/07/2014, Compliance check: Xpantoprazole (in combination with amoxicillin + clarithromycin + metronidazole … pantoprazole (in combination with amoxicillin + clarithromycin + metronidazole … pantoprazole (in combination with amoxicillin + clarithromycin + metronidazole … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): pantoprazole
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Other
PIP number: EMEA-002512-PIP01-18, Route(s) of administration: Oral use, Pharmaceutical form(s): Tablet
Decision date: 15/05/2019, Last updated: 29/10/2019, Compliance check: Xpantoprazole (in combination with amoxicillin + clarithromycin) (EMEA-002512-PIP01-18 … -
List item
Press release: Committee for Medicinal Products for Veterinary Use (CVMP): Meeting of 5-7 April 2011
CVMP, Last updated: 08/04/2011amoxicillin, clavulanic acid and prednisolone … Intramammary Suspension (amoxicillin, clavulanic acid and prednisolone … Intramammary Suspension (amoxicillin, clavulanic acid and prednisolone … -
List item
News: EMA Management Board: highlights of March 2023 meeting
MB, Last updated: 17/03/2023containing the antibiotic amoxicillin. Since the last Board meeting … involved in the supply chain of amoxicillin to provide regulatory support … -
List item
National expert: Edurne Lazaro, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 39.31 KB | PDF
- Curriculum Vitae - 30.61 KB | PDF
moxifloxacin, levofloxacin and amoxicillin/clavulanic acid. Cuevas O, Oteo J, Lázaro … for beta_lactamase_negative amoxicillin_resistant isolates, in parallel with … -
List item
Press release: Committee for Medicinal Products for Veterinary Use (CVMP): Meeting of 13-15 July 2010
CVMP, Last updated: 16/07/2010amoxicillin, clavulanic acid and prednisolone … Intramammary Suspension (amoxicillin, clavulanic acid and prednisolone … Intramammary Suspension (amoxicillin, clavulanic acid and prednisolone … -
List item
National expert: Raul Belmar Liberato, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 40.04 KB | PDF
- Curriculum Vitae - 28.83 KB | PDF
PP, Escribano_Salazar M. Amoxicillin and amoxicillin_clavulanic acid resistance in veterinary … -
List item
National expert: María Isabel Lucena, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 39.44 KB | PDF
- Curriculum Vitae - 43.93 KB | PDF
-
List item
Press release: Committee for Medicinal Products for Veterinary Use (CVMP): Meeting of 7-9 June 2011
CVMP, Last updated: 10/06/2011amoxicillin and clavulanic acid) from … tablet for cats and dogs (amoxicillin and clavulanic acid) from … Cow and associated names (amoxicillin trihydrate, potassium clavulanate … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,18-21 February 2008
CHMP, Last updated: 21/02/2008amoxicillin/clavulanic acid), from GSK, because … -
List item
National expert: Emilia Cercenado Mansilla, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 41.48 KB | PDF
- Curriculum Vitae - 468.19 KB | PDF
-
List item
National expert: Mair Powell, Health Products Regulatory Authority (updated)
- Declaration of interests - 39.2 KB | PDF
- Curriculum Vitae - 29.16 KB | PDF
of aztreonam, imipenem and amoxycillin_clavulanate against ampicillin_resistant … -
List item
National expert: Paulo Paixão, National Authority Of Medicines And Health Products (updated)
- Declaration of interests - 39.36 KB | PDF
- Curriculum Vitae - 38.91 KB | PDF
Montanha, M. C.; Kimura, E. Amoxicillin dosing and pharmacokinetics … Kimura; “Pharmacokinetics of amoxicillin in obese and nonobese subjects” … Bypass Bariatric Patients: Amoxicillin Tablet and Suspension.” … -
List item
National expert: Jesus Chesa Jimenez, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 39.42 KB | PDF
- Curriculum Vitae - 32.17 KB | PDF
L. Low bioavalability of amoxycillin in the rat as a consequence … -
List item
National expert: Sandra De Boever, Federal Agency for Medicines and Health Products (updated)
- Declaration of interests - 40.26 KB | PDF
- Curriculum Vitae - 34.09 KB | PDF
-
List item
National expert: Aránzazu González-Canga, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 39.45 KB | PDF
- Curriculum Vitae - 74.01 KB | PDF
-
List item
National expert: Pieter Colin, Federal Agency for Medicines and Health Products (updated)
- Declaration of interests - 40.02 KB | PDF
- Curriculum Vitae - 42.69 KB | PDF
W., Eloot S. Optimizing Amoxicillin/Clavulanic Acid Dosing Regimens in Patients … -
List item
National expert: Dominique Ploin, National Agency For The Safety Of Medicine And Health Products (updated)
- Declaration of interests - 39.92 KB | PDF
- Curriculum Vitae - 37.42 KB | PDF
-
List item
Human medicine European public assessment report (EPAR): Sirturo (updated)
bedaquiline fumarate, Tuberculosis, Multidrug-Resistant
Date of authorisation: 05/03/2014,
, 
, 
, Revision: 21, Authorised, Last updated: 16/05/2023
-
List item
Human medicine European public assessment report (EPAR): Zerbaxa
ceftolozane sulfate, tazobactam sodium, Bacterial Infections
Date of authorisation: 18/09/2015, Revision: 15, Authorised, Last updated: 14/04/2023 -
List item
Human medicine European public assessment report (EPAR): Libtayo (updated)
Cemiplimab, Carcinoma, Squamous Cell
Date of authorisation: 28/06/2019,, Revision: 14, Authorised, Last updated: 17/05/2023
-
List item
Human medicine European public assessment report (EPAR): Skyrizi
Risankizumab, Psoriasis; Arthritis, Psoriatic
Date of authorisation: 26/04/2019,, Revision: 15, Authorised, Last updated: 04/04/2023
-
List item
Human medicine European public assessment report (EPAR): Granupas (previously Para-aminosalicylic acid Lucane)
Para-aminosalicylic acid, Tuberculosis
Date of authorisation: 07/04/2014,, Revision: 11, Authorised, Last updated: 26/04/2023